This Market Stinks. So Hold Your Nose and Follow These Rules
Here's one stock I'm watching amid the depressing action.
You're reading 0 of 1 free page.
Register to read more or Unlock Pro — 50% Off Ends Soon
The market action right now can be summed up in two words: "It stinks."
So, let's take a look at how stocks are performing, one I'm eyeing now and my portfolio plan.
Mag 7 Weakness
We saw a fleeting attempt to buy the dip in the Magnificent Seven (MAGS ) tech stocks, but that lasted only minutes before the freefall resumed. The group is now trading decisively below its 200-day simple moving average, and downside momentum is clearly accelerating.
This weakness in big-cap tech is particularly painful because we aren't seeing a healthy rotation into other sectors. Market breadth is negative, and while the Russell 2000 (IWM) isn't getting hit quite as hard as the Nasdaq 100 (QQQ) — which is today's biggest laggard with a 1.3% loss — the upside moves across the board are minuscule at best.
Year-to-Date Performance
The indexes are hitting intraday lows as I write this. I’m not going to be tempted to risk precious capital right now.
Searching for Safe Havens
Finding a place to hide in this environment is proving to be a massive challenge. Energy and oil have shown some life recently, and Apple (AAPL) is seeing some defensive interest, but the real standout has been Walmart (WMT) . I was at Sam’s Club this weekend, and while I didn't see any Lambos in the parking lot, the place was absolutely packed. It seems investors are flocking to where the consumers are still spending.
Portfolio Game Plan
How do you navigate this mess? The short answer is patience.
- Avoid Aggressive Bottom Fishing: You might get lucky with a quick counter-trend bounce, but it is way too early to start building long-term positions.
- Stop Trying to Time the Low: Don’t be the "hero" trying to catch the exact bottom tick on your favorite names.
- Wait for Support: Look for signs of actual price stabilization and evidence that buyers are starting to nibble before you commit capital.
- Keep Your Firepower: The only thing worse than a terrible market is being fully tied up when the real opportunity finally emerges. You need flexibility and cash to move aggressively when upside momentum eventually returns.
Spotlight: Cullinan Therapeutics
I want to highlight Cullinan Therapeutics (CGEM) as a prime example of the current "fundamentals don't matter" environment. On Feb. 3, I noted a near-perfect chart setup; the stock broke out to new highs, but it simply couldn't hold up against this broader market pressure.
On Tuesday morning, TheFly reported that Citi initiated coverage with a Buy rating and a $33 price target, citing a "catalyst-rich" 2026 and favorable risk/reward ahead of the CLN-978 readouts. This follows Guggenheim's initiation with a $30 target earlier this month.
With the stock trading near $11.65, those targets represent massive potential returns. However, in this tape, price action matters more than analyst reports. I am holding my current shares, but I won’t be adding more until I see a meaningful shift in the charts.
At the time of publication, DePorre was long CGEM.
